Literature DB >> 15572025

Cross-talk between pRb/E2F and Wnt/beta-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death.

Thomas A Hughes1, Hugh J M Brady.   

Abstract

The pRb/E2F and Wnt/beta-catenin pathways are two of the most frequently deregulated pathways in human cancers. In this study, we show that E2F1 up-regulates the expression of axin2. Further, we show that axin2 can repress Wnt signalling leading to reduced cell growth and increased cell death. This represents cross-talk between major pathways involved in the formation of tumours. We use our data to suggest a novel mechanism for tumour suppression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15572025     DOI: 10.1016/j.yexcr.2004.09.014

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

1.  Comparison of the effects of 40% oxygen and two atmospheric absolute air pressure conditions on stress-induced premature senescence of normal human diploid fibroblasts.

Authors:  Sangnam Oh; Eunil Lee; Joohyun Lee; Yongchul Lim; Joonhee Kim; Samyong Woo
Journal:  Cell Stress Chaperones       Date:  2008-05-09       Impact factor: 3.667

2.  Upregulation of E2F1 in cerebellar neuroprogenitor cells and cell cycle arrest during postnatal brain development.

Authors:  Daniela E Suzuki; Carolina B Ariza; Marimélia A Porcionatto; Oswaldo Keith Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-05-26       Impact factor: 2.416

3.  Epigenetic and genetic analysis of WNT signaling pathway in sporadic colorectal cancer patients from Iran.

Authors:  Fakhraddin Naghibalhossaini; Mozhdeh Zamani; Pooneh Mokarram; Islam Khalili; Mozhgan Rasti; Zohreh Mostafavi-Pour
Journal:  Mol Biol Rep       Date:  2011-12-30       Impact factor: 2.316

4.  Cell cycle control of Wnt/β-catenin signalling by conductin/axin2 through CDC20.

Authors:  Michel V Hadjihannas; Dominic B Bernkopf; Martina Brückner; Jürgen Behrens
Journal:  EMBO Rep       Date:  2012-04       Impact factor: 8.807

5.  Functional and association analysis of frizzled 1 (FZD1) promoter haplotypes with femoral neck geometry.

Authors:  Yingze Zhang; Allison L Kuipers; Laura M Yerges-Armstrong; Cara S Nestlerode; Zhao Jin; Victor W Wheeler; Alan L Patrick; Clareann H Bunker; Joseph M Zmuda
Journal:  Bone       Date:  2010-01-04       Impact factor: 4.398

6.  Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets.

Authors:  Piyush B Madhamshettiwar; Stefan R Maetschke; Melissa J Davis; Antonio Reverter; Mark A Ragan
Journal:  Genome Med       Date:  2012-05-01       Impact factor: 11.117

7.  In vitro functional effects of XPC gene rare variants from bladder cancer patients.

Authors:  Boling Qiao; Abdul-Haq Ansari; Gina B Scott; Sei C Sak; Philip A Chambers; Faye Elliott; Mark T W Teo; Johanne Bentley; Michael Churchman; Janet Hall; Claire F Taylor; Timothy D Bishop; Margaret A Knowles; Anne E Kiltie
Journal:  Carcinogenesis       Date:  2011-01-27       Impact factor: 4.944

8.  Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer.

Authors:  Sampoorna Satheesha; Victoria J Cookson; Louise J Coleman; Nicola Ingram; Brijesh Madhok; Andrew M Hanby; Charlotte A B Suleman; Vicky S Sabine; E Jane Macaskill; John M S Bartlett; J Michael Dixon; Jim N McElwaine; Thomas A Hughes
Journal:  Mol Cancer       Date:  2011-02-14       Impact factor: 27.401

9.  Differential regulation of oestrogen receptor β isoforms by 5' untranslated regions in cancer.

Authors:  Laura Smith; Rebecca A Brannan; Andrew M Hanby; Abeer M Shaaban; Eldo T Verghese; Mark B Peter; Steven Pollock; Sampoorna Satheesha; Marcin Szynkiewicz; Valerie Speirs; Thomas A Hughes
Journal:  J Cell Mol Med       Date:  2010-01-01       Impact factor: 5.310

10.  AIF inhibits tumor metastasis by protecting PTEN from oxidation.

Authors:  Shao-Ming Shen; Meng Guo; Zhong Xiong; Yun Yu; Xu-Yun Zhao; Fei-Fei Zhang; Guo-Qiang Chen
Journal:  EMBO Rep       Date:  2015-09-28       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.